Concentric Analgesics

Concentric Analgesics, Inc. is a San Francisco based clinical-stage biopharmaceutical company developing non-opioid pain therapeutics. Its lead candidate, vocacapsaicin (CA-008), is a first-in-class prodrug that converts to capsaicin, a TRPV1 agonist that selectively desensitizes pain-conducting nerve fibers without sensory numbness or motor weakness, given as a single local injection during surgery. The program holds FDA Fast Track designation (2017) and Breakthrough Therapy designation (2018), and has been evaluated in Phase 2 trials in bunionectomy, total knee arthroplasty and open ventral hernia repair. The company is a drug developer, not a software vendor: it publishes no API, SDK, developer portal or other machine-readable surface, and as of this check its corporate website is an expired Squarespace account that returns HTTP 404 for every path.

Concentric Analgesics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Clinical Trials.

🌐 Visit website 📡 Source on GitHub
3.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesClinical TrialsDrug DevelopmentHealthcarePain Management

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 3.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/concentric-analgesics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: concentric-analgesics
name: Concentric Analgesics
description: 'Concentric Analgesics, Inc. is a San Francisco based clinical-stage biopharmaceutical company developing non-opioid
  pain therapeutics. Its lead candidate, vocacapsaicin (CA-008), is a first-in-class prodrug that converts to capsaicin, a
  TRPV1 agonist that selectively desensitizes pain-conducting nerve fibers without sensory numbness or motor weakness, given
  as a single local injection during surgery. The program holds FDA Fast Track designation (2017) and Breakthrough Therapy
  designation (2018), and has been evaluated in Phase 2 trials in bunionectomy, total knee arthroplasty and open ventral hernia
  repair. The company is a drug developer, not a software vendor: it publishes no API, SDK, developer portal or other machine-readable
  surface, and as of this check its corporate website is an expired Squarespace account that returns HTTP 404 for every path.'
url: https://raw.githubusercontent.com/api-evangelist/concentric-analgesics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-09'
modified: '2026-08-09'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Clinical Trials
- Drug Development
- Healthcare
- Pain Management
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://forgeglobal.com/concentric-analgesics_stock/
x-enrichment:
  date: '2026-08-09'
  status: nochange
  artifacts_added: 0
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Concentric Analgesics is a clinical-stage biopharmaceutical company whose product is a drug (vocacapsaicin/CA-008),
    not software; there is no developer surface to find, and its corporate site at www.concentricanalgesics.com is now an
    expired Squarespace account that returns 404 for the homepage and every archived press-release path.
  evidence:
  - url: https://www.concentricanalgesics.com/
    status: 404
  - url: https://www.concentricanalgesics.com/pipeline
    status: 404
  - url: https://www.concentricanalgesics.com/.well-known/agent-card.json
    status: 404
  - url: https://www.concentricanalgesics.com/openapi.json
    status: 404
  - url: https://api.github.com/orgs/concentric-analgesics
    status: 404
  checked: '2026-08-09'